Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Added Value of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography to Magnetic Resonance Imaging for Local Staging of Prostate Cancer in Patients Undergoing Radical Prostatectomy.
Soeterik TFW, Heetman JG, Hermsen R, Wever L, Lavalaye J, Vinken M, Bahler CD, Yong C, Tann M, Kesch C, Seifert R, Telli T, Chiu PK, Wu KK, Zattoni F, Evangelista L, Bettella S, Ceci F, Barone A, Miszczyk M, Matsukawa A, Rajwa P, Marra G, Briganti A, Montorsi F, Scheltema MJ, van Basten JA, van Melick HHE, van den Bergh RCN, Gandaglia G; European Association of Urology Young Academic Urologists Prostate Cancer Working Party. Soeterik TFW, et al. Among authors: telli t. Eur Urol Oncol. 2024 Nov 28:S2588-9311(24)00249-9. doi: 10.1016/j.euo.2024.11.002. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39613565 Free article.
Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study.
Karpinski MJ, Hüsing J, Claassen K, Möller L, Kajüter H, Oesterling F, Grünwald V, Umutlu L, Kleesiek J, Telli T, Merkel-Jens A, Hüsing A, Kesch C, Herrmann K, Eiber M, Hoberück S, Meyer PT, Kind F, Rahbar K, Schäfers M, Stang A, Hadaschik BA, Fendler WP. Karpinski MJ, et al. Among authors: telli t. Lancet Oncol. 2024 Sep;25(9):1188-1201. doi: 10.1016/S1470-2045(24)00326-7. Epub 2024 Jul 29. Lancet Oncol. 2024. PMID: 39089299 Free article.
The association of quantitative PSMA PET parameters with pathologic ISUP grade: an international multicenter analysis.
Soeterik TFW, Heetman JG, Hermsen R, Wever L, Lavalaye J, Vinken M, Bahler CD, Yong C, Tann M, Kesch C, Seifert R, Telli T, Chiu PK, Wu KK, Zattoni F, Evangelista L, Segalla E, Barone A, Ceci F, Rajwa P, Marra G, Mazzone E, Van Basten JA, Van Melick HHE, Van den Bergh RCN, Gandaglia G; EAU-YAU Prostate Cancer Working Party. Soeterik TFW, et al. Among authors: telli t. Eur J Nucl Med Mol Imaging. 2024 Dec;52(1):314-325. doi: 10.1007/s00259-024-06847-y. Epub 2024 Aug 1. Eur J Nucl Med Mol Imaging. 2024. PMID: 39088067 Free PMC article.
PSMA-PET follow-up to assess response in patients not receiving PSMA therapy: Is there value beyond localization of disease?
Küper AT, Kersting D, Telli T, Herrmann K, Rominger A, Afshar-Oromieh A, Lopes L, Karkampouna S, Shi K, Kim M, Hadaschik B, Darr C, Umutlu L, Fendler WP, Seifert R. Küper AT, et al. Among authors: telli t. Theranostics. 2024 Jun 11;14(9):3623-3633. doi: 10.7150/thno.96738. eCollection 2024. Theranostics. 2024. PMID: 38948055 Free PMC article.
Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study.
Flippot R, Telli T, Velev M, Fléchon A, De Vries-Brilland M, Turpin L, Bergman A, Turco F, Mahammedi H, Fendler WP, Giraudet AL, Josset Q, Montravers F, Vogel W, Gillessen S, Berardi Vilei S, Herrmann K, Kryza D, Paone G, Hadaschik B, Merlin C, Dufour PA, Bernard-Tessier A, Naoun N, Patrikidou A, Garcia C, Foulon S, Pagès A, Fizazi K. Flippot R, et al. Among authors: telli t. Eur Urol Oncol. 2024 Oct;7(5):1132-1140. doi: 10.1016/j.euo.2024.03.013. Epub 2024 Apr 24. Eur Urol Oncol. 2024. PMID: 38664139
Prognostic Value of Circulating Cytokines in Chemorefractory Colorectal Cancer.
Assaf I, Fimereli D, Anthoine G, Fazio R, Daprà V, Audisio A, Bardiaux A, Telli TA, Vanhooren M, Saude-Conde R, Bregni G, Hendlisz A, Sclafani F. Assaf I, et al. Among authors: telli ta. Cancers (Basel). 2023 Dec 13;15(24):5823. doi: 10.3390/cancers15245823. Cancers (Basel). 2023. PMID: 38136368 Free PMC article.
What Role Does PET/MRI Play in Musculoskeletal Disorders?
Telli T, Desaulniers M, Pyka T, Caobelli F, Forstmann S, Umutlu L, Fendler WP, Rominger A, Herrmann K, Seifert R. Telli T, et al. Semin Nucl Med. 2023 Dec 2:S0001-2998(23)00091-0. doi: 10.1053/j.semnuclmed.2023.11.004. Online ahead of print. Semin Nucl Med. 2023. PMID: 38044175 Review.
The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey.
Akyildiz A, Guven DC, Ozluk AA, Ismayilov R, Mutlu E, Unal OU, Yildiz I, Iriagac Y, Turhal S, Akbas S, Bayram E, Telli TA, Turkoz FP, Ozcelik M, Erciyestepe M, Selvi O, Gulbagci B, Erturk I, Isleyen ZS, Kahraman S, Akdag MO, Hamitoglu B, Unek IT, Unal C, Hacibekiroglu İ, Arslan C, Azizy A, Helvaci K, Demirci U, Dizdar O, Basaran M, Goker E, Sendur MA, Yalcin S. Akyildiz A, et al. Among authors: telli ta. Medicine (Baltimore). 2023 Nov 10;102(45):e35950. doi: 10.1097/MD.0000000000035950. Medicine (Baltimore). 2023. PMID: 37960746 Free PMC article.
53 results